Clindamycin vs Ipilimumab

## Clindamycin vs Ipilimumab: Overview

This comparison examines the pharmacological differences between **Clindamycin** and **Ipilimumab**.

## Mechanism of Action

**Clindamycin**: Binds 50S ribosomal subunit inhibiting protein synthesis.

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

## Pharmacokinetics

**Half-life**: Clindamycin — 2-3 hours; Ipilimumab — 14.7 days.

## Chemical Properties

**Molecular Formula**: Clindamycin — C18H33ClN2O5S; Ipilimumab — N/A.

**Molecular Weight**: Clindamycin — 424.9830 g/mol; Ipilimumab — N/A.

**Type**: Clindamycin — Small molecule; Ipilimumab — Antibody.